IP Library Granted Patent US 8,870,851
Granted Patent B2
US 8,870,851 · App. 13/687,677 · Granted Oct 28, 2014

Reduced pressure treatment system having blockage clearing and dual-zone pressure protection capabilities

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,870,851
App. No.
13/687,677
Granted
Oct 28, 2014
Kind
B2
Abstract

A method of treating a tissue site is provided. The method includes applying a reduced pressure to a tissue site with a reduced pressure source. A source pressure is monitored at the reduced pressure source, and a differential pressure is determined between the source pressure and the desired tissue site pressure. If a blockage is present between the reduced pressure source and the tissue site, the differential pressure is limited to a first maximum differential pressure. If no blockage is present between the reduced pressure source and the tissue site, the differential pressure is limited to a second maximum differential pressure.

Claims (39)

1. Apparatus for detecting a blockage between a tissue site and a reduced pressure source fluidly connected to the tissue site, comprising:

a sensing device adapted to be in communication with the reduced pressure source to measure a source pressure corresponding to the output of the reduced pressure source;

an input/output unit in communication with the sensing device and adapted to be in communication with the reduced pressure source; and

a processing unit in communication with the input/output unit to regulate the output of the reduced pressure source in response to the source pressure, the processing unit being configured to calculate a differential pressure between the source pressure and a target pressure and to regulate the output of the reduced pressure source such that the differential pressure does not exceed (a) a first maximum differential pressure if a blockage is present between the reduced pressure source and the tissue site and (b) a second maximum differential pressure if a blockage is not present between the reduced pressure source and the tissue site.

2. The system according to claim 1 further comprising:

a canister fluidly connected between the tissue site and the reduced pressure source; and

wherein the sensing device measures the source pressure at the canister to approximate a pressure output of the reduced pressure source.

3. The apparatus according to claim 1 , wherein the second maximum differential pressure is greater than the first maximum differential pressure.

4. The apparatus according to claim 1 , wherein the first maximum differential pressure is about 50 mm Hg.

5. The apparatus according to claim 1 , wherein the second maximum differential pressure is about 100 mm Hg.

6. The apparatus according to claim 1 , wherein:

when the blockage is present, the processing unit is further configured to increase the source pressure, within a limit of the first maximum differential pressure, to clear the blockage.

7. The apparatus according to claim 6 , further comprising:

an alarm device in communication with the processing unit to alert a user when the blockage is unable to be cleared after reaching the first maximum differential pressure.

8. The apparatus according to claim 1 , wherein the processing unit is further configured to change the source pressure, within a limit of one of the first and second maximum differential pressures, to cause a pressure at the tissue site to reach the desired tissue site pressure.

9. The system according to claim 8 , wherein the processing unit determines that the blockage is present when no directionally corresponding change in the pressure at the tissue site occurs by changing the source pressure.

10. The apparatus according to claim 1 , wherein the processing unit is further configured to check for the presence of the blockage by changing the source pressure and monitoring for a change in a pressure at the tissue site.

11. The system according to claim 1 further comprising:

a second sensing device, the second sensing device monitoring the tissue site to determine if a pressure at the tissue site reaches the desired tissue site pressure.

12. A method for controlling application of reduced pressure from a reduced pressure source to a tissue site, comprising:

monitoring a source pressure corresponding to the output of the reduced pressure source;

determining a differential pressure between the source pressure and a target pressure;

regulating the reduced pressure source by limiting the differential pressure to a first maximum differential pressure in response to a blockage being present between the reduced pressure source and the tissue site; and

regulating the reduced pressure source by limiting the differential pressure to a second maximum differential pressure in response to a blockage not being present between the reduced pressure source and the tissue site.

13. The method according to claim 12 , wherein the second maximum differential pressure is greater than the first maximum differential pressure.

14. The method according to claim 12 , wherein the first maximum differential pressure is about 50 mm Hg.

15. The method according to claim 12 , wherein the second maximum differential pressure is about 100 mm Hg.

16. The method according to claim 12 , wherein the step of determining the differential pressure further comprises monitoring the differential pressure.

17. The method according to claim 12 further comprising:

when a blockage is present, increasing the source pressure within the limits of the first maximum differential pressure to attempt to clear the blockage.

18. The method according to claim 12 further comprising:

increasing the source pressure within the limits of the first maximum differential pressure when a blockage is present to attempt to clear the blockage; and

generating an alarm if the blockage does not clear to indicate that a blockage is still present.

19. The method according to claim 12 further comprising:

changing the source pressure within the limits of one of the first maximum differential pressure and the second maximum differential pressures to cause the output of the reduced pressure source to reach the target pressure.

20. The method according to claim 12 , further comprising:

determining if a blockage is present by changing the source pressure and monitoring for a directionally corresponding change in a pressure at the tissue site; and

determining that a blockage is present when no directionally corresponding change occurs in the pressure at the tissue site.

21. The method according to claim 20 , wherein changing the source pressure further comprises increasing the source pressure.

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066430/0333 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064790/0085 →
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
RELEASE OF SECURITY INTEREST REEL/FRAME 040098/0268 Recorded Feb 8, 2017
From: WILMINGTON TRUST
To: KCI USA, INC.
Reel/Frame 041666/0320 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 3, 2013
From: KELCH, RANDALL P.; ZHENG, XIAOLU; EDGAR, JR., REUBEN W.; JAEB, JONATHAN PAUL; LAWHORN, THOMAS PAUL; INGRAM, SHANNON C.
To: KCI LICENSING, INC.
Reel/Frame 031124/0100 →